Evidence map›Paper›PMID 29892216›Full record

ArticleFrontiers in behavioral neuroscience2018

Ameliorating Impact of Prophylactic Intranasal Oxytocin on Signs of Fear in a Rat Model of Traumatic Stress.

Micah D Renicker, Nicholas Cysewski, Samuel Palmer, Dmytro Nakonechnyy, Andrew Keef, Morgan Thomas, Krisztian Magori, David P Daberkow

Open access · goldAbstract read
In one paragraph

Article in Frontiers in behavioral neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Micah D RenickerDepartment of Biology, Eastern Washington University, Cheney, WA, United States.
Nicholas CysewskiDepartment of Biology, Eastern Washington University, Cheney, WA, United States.
Samuel PalmerDepartment of Biology, Eastern Washington University, Cheney, WA, United States.
Dmytro NakonechnyyDepartment of Biology, Eastern Washington University, Cheney, WA, United States.
Andrew KeefDepartment of Biology, Eastern Washington University, Cheney, WA, United States.
Morgan ThomasDepartment of Biology, Eastern Washington University, Cheney, WA, United States.
Krisztian MagoriDepartment of Biology, Eastern Washington University, Cheney, WA, United States.
David P DaberkowDepartment of Biology, Eastern Washington University, Cheney, WA, United States.
Eastern Washington University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxytocin treatment reduces signs of long-term emotional stress after exposure to trauma; however, little is known about the potential protective effects of oxytocin treatment on behavioral and physiological changes associated with extreme stress exposure. The objective of this study was to investigate oxytocin treatment as a prophylactic measure against rat signs of fear. Two separate experiments were conducted in which the time of intranasal oxytocin administration differed. Intranasal oxytocin (1.0 μg/kg) was administered 5 min after daily exposure to foot shock in Experiment #1 and 1 h before foot shock in Experiment #2. In Experiment #1, possible massage-evoked oxytocin release (5 min after foot shock) was also investigated. In both experiments, a contextual fear conditioning procedure was employed in which stress was induced via inescapable foot shock (3 days, 40 shocks/day, 8 mA/shock) in a fear conditioning chamber. Male Sprague-Dawley rats (

Indexed as

fearintranasaloxytocinPTSDstress

Identifiers

PMID29892216
PMCPMC5985313
OpenAlexW2807076239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.